Head-to-head · Cost-Efficiency Index
Corsica Health vs NuvaHealth
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
Corsica Health
Shoppers who want compounded and brand-name GLP-1 pricing shown side by side on one platform.
Visit Corsica HealthNuvaHealth
Shoppers comfortable finding out the real recurring price only at checkout.
Visit NuvaHealthThe verdict
Corsica Health and NuvaHealth tie on the Cost-Efficiency Index at 66/100, so neither wins outright on the numbers. For most shoppers we'd start with Corsica Health (ranked #146, a hair above #149) — Shoppers who want compounded and brand-name GLP-1 pricing shown side by side on one platform. But NuvaHealth is a genuine coin-flip alternative here.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the ranking). See how it stacks up: CoreAge Rx vs Corsica Health.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | Corsica Health | NuvaHealth |
|---|---|---|
| Cost-Efficiency Index | 66/100 | 66/100 |
| Semaglutide / mo | $149/mo (starting dose, compounded) | $89/mo (starting dose, first-month rate, compounded) |
| Tirzepatide / mo | $249/mo (starting dose, compounded) | $139/mo (starting dose, first-month rate, compounded) |
| Semaglutide / yr (modeled) | $1,788 | $1,068 |
| Tirzepatide / yr (modeled) | $2,988 | $1,668 |
| Coverage | Coverage not published | Coverage not published |
| Oral / sublingual | No | No |
| Brand-name access | Yes | Compounded only |
| Rank here | #146 | #149 |
Corsica Health
66/100Where the value is
- Publishes real starting dollar prices for THREE tiers on one page — compounded semaglutide, compounded tirzepatide, and brand-name Ozempic/Wegovy — a genuine transparency advantage few competitors offer at once
- Compounded semaglutide's starting price fell from $199/mo to $149/mo since a prior 2026-07-20 check — a real, verifiable decrease
- Free shipping and provider consultation included in the listed starting price
The tradeoffs
- Listed prices are floor figures for the lowest dose tier only — no published ladder for what higher, titrated doses cost
- The '15-20% average weight change' and '4.8/5 satisfaction' figures are the company's own self-reported claims, not independently sourced
NuvaHealth
66/100Where the value is
- LegitScript certified with a working verification badge
- Names four real pharmacy partners (Belmar, Strive, Epiq Scripts, Casa Pharma Rx) rather than one anonymous 'licensed pharmacy'
- All 50 states served per its own FAQ
The tradeoffs
- The headline $89/$139 prices are explicitly first-month-only per NuvaHealth's own FAQ — the real month-two-plus recurring price is not published anywhere and only appears at checkout after intake
- No named prescriber or medical director anywhere on the site
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.